ROYCE & ASSOCIATES LP - FURIEX PHARMACEUTICALS INC ownership

FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101. A total of 108 filers reported holding FURIEX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 7.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of FURIEX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2014$30,891,000
+82.2%
355,065
-12.0%
0.09%
+85.7%
Q4 2013$16,954,000
+65.5%
403,565
+73.3%
0.05%
+63.3%
Q3 2013$10,244,000
+346.2%
232,865
+245.6%
0.03%
+328.6%
Q2 2013$2,296,00067,3830.01%
Other shareholders
FURIEX PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Magnetar Financial LLC 950,000$100,871,0001.68%
Camber Capital Management LP 200,000$21,236,0001.39%
OXFORD ASSET MANAGEMENT LLP 378,901$40,080,0001.30%
Magnetar Financial LLC 734,006$77,937,0001.30%
HARVEST MANAGEMENT LLC 10,077$1,070,0001.08%
FRANKLIN STREET ADVISORS INC /NC 48,755$5,177,0000.99%
ARROWGRASS CAPITAL PARTNERS (US) LP 251,319$26,685,0000.78%
Biondo Investment Advisors, LLC 19,385$2,058,0000.65%
Andromeda Capital LLC 75,100$7,974,0000.56%
CSS LLC/IL 126,200$13,399,0000.56%
View complete list of FURIEX PHARMACEUTICALS INC shareholders